Target intelligence / Profile preview

CMC1 pseudogene 1 (CMC1P1)

Target
CMC1P1
Molecular classification
Pseudogene
01

Overview

CMC1 pseudogene 1 (abbreviated CMC1P1) is a pseudogene, which means it is a genomic DNA sequence similar to a functional gene but generally considered non-coding and non-functional due to disabling mutations. Pseudogenes do not encode functional proteins and are not recognized as direct targets for drug development or therapy. While some pseudogenes have recently been implicated in gene expression regulation and disease association through RNA-based regulatory mechanisms (such as competing for microRNAs), there is no publicly available evidence indicating that CMC1P1 has such functions[2][3][4][5]. Additional context: Pseudogenes are typically classified into three molecular types: unitary, unprocessed (duplicated), and processed pseudogenes (retrotransposed)[4]. They are, in general, considered biologically inert, though a minority can impact gene regulation through RNA-level interactions in some contexts[3][4]. However, such roles must be established individually; no such function has been reported for CMC1P1. If your interest is in a functional molecule or target, a different name or identifier may be needed, as CMC1P1 does not correspond to an established target class.

02

Biological functions

Other (Some pseudogenes can have regulatory roles—such as functioning as competing endogenous RNA or microRNA sponges—but no functional data is available specifically for CMC1P1)For most pseudogenes, no direct biological function has been established.
03

Disease associations

Other (There is no disease association documented for CMC1P1 specifically; some pseudogenes in general may have regulatory roles in disease[2][4], but this is not established)

Beyond the preview

Go deeper on CMC1 pseudogene 1 (CMC1P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CMC1 pseudogene 1 (CMC1P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call